29 Sep, 2016
HyTest posters at the 4th Joint EFLM-UEMS Congress
Our researchers presented four posters at the EFLM-UEMS Congress recently held in Warsaw, Poland.
Read more
29 Sep, 2016
Paul White joins the HyTest Board
We are delighted to announce that Mr. Paul White has joined the HyTest Board of Directors with effect from September 2016.
Read more
31 Aug, 2016
Sales Growth Continues in the First Half 2016
During the first half of 2016, HyTest was able to continue its strong growth. Its...
Read more
31 Aug, 2016
Review about Natriuretic Peptides in the Latest eJIFCC
BNP and NT-proBNP are widely accepted biomarkers of heart failure. However, we...
Read more
16 Aug, 2016
HyTest Attends ECVIM-CA Congress in September 2016
We will be present at the ECVIM-CA congress, which is held in Svenska Massan...
Read more
14 Jul, 2016
Antibodies and antigen for the detection of Lp-PLA2, a marker of coronary heart disease
We provide five in vitro-produced monoclonal antibodies that are specific to human Lp-PLA2. They can be used for the development of quantitative immunoassays which enable the detection of Lp-PLA2 from plasma samples. In addition, we provide recombinant human Lp-PLA2.
Read more
08 Jul, 2016
Meet HyTest Team at AACC 2016 Philadelphia
HyTest will be participating the 2016 AACC Annual Meeting & Clinical Lab Expo.
Read more
31 May, 2016
Entresto™ and Neprilysin: Not So Clear Cut of B-type Natriuretic Peptides?
A recently introduced heart failure drug Entresto™ (LCZ696) has been suggested to increase...
Read more
30 May, 2016
HyTest Participates in ACVIM 2016 Veterinary Conference
We will be present at the Forum of American College of Veterinary Internal Medicine...
Read more
26 Apr, 2016
Positive Development for HyTest’s 2015 Sales and Profitability – Growth in Future Also in Veterinary Diagnostics Reagents
Despite the global economic challenges, HyTest was able to grow corporate sales by...
Read more
26 Apr, 2016
Prof. Fred S. Apple Joins HyTest Board
We are delighted to announce that Prof. Fred S. Apple joined the HyTest Board of Directors in April 2016.
Read more
30 Mar, 2016
CMEF in China
HyTest participates the CMEF in Shanghai, China on April 17-20, 2016.
Read more
25 Feb, 2016
HyTest Attends CACLP Expo in China
HyTest participates in the 13th China Association of Clinical Laboratory Practice Expo held in Qujiang International Conference & Exhibition Center, Xi’an, 7 – 9, March.
Read more
17 Dec, 2015
Season's Greetings 2015
Thank you for being part of our year!
Read more
28 Oct, 2015
HyTest Participating Medica 2015
HyTest participates in MEDICA 2015 - the World's Leading Medical Forum - from November 16 to19.
Read more
21 Oct, 2015
Maria Severina, HyTest Managing Director, Regional Winner of the EY Entrepreneur of the Year 2015 Competition
On the 19th October Maria Severina was chosen as a regional winner of West Finland in the category production.
Read more
29 Sep, 2015
White paper: Natriuretic peptides, heart failure and LCZ696
The newly FDA-approved heart failure drug (Entresto®) has caused significant excitement as the clinical studies have shown considerably better therapy outcomes for patients suffering from heart failure.
Read more
01 Sep, 2015
Strong Growth in Sales During the First Half of 2015
HyTest was able to continue its strong growth during the first half of 2015. Consolidated revenue grew to 9.2 million euros, which represented an increase of 18% compared to the first half of the previous year.
Read more
23 Jun, 2015
HyTest SES-BNP and IGFBP-4 Patents
We are delighted to announce the news that HyTest has been granted a patent in the United States for SES-BNP technology and IGFBP-4 fragments in Finland, France, Germany, Sweden and the United Kingdom.
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!